about
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr ...
Read More193.0K XNAS Volume
XNAS 06 Jun, 2025 9:49 AM (EDT)
Board Meeting
The next board meeting for Pulmonx Corp is on 11 Jun 2025 for the purpose of oldman Sachs 46th Annual Global Health Care Conference
See details
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Pulmonx Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..